logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (vii) All inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives11.428.716.
Volatile substances53.
Cannabis 35.346.611.
Other substances


 : indicates data not available 

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU, AT, RO, SK, FI, SE, HR, TR. 

 Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2008 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009